Cutaneous infection and atopic dermatitis: the importance of early intervention in Indigenous children in Australia.
There are dramatic disparities in the life expectancy, health and healthcare access between Indigenous and non-Indigenous Australians. The burden of chronic disease is significantly elevated and contributed to by multiple socioeconomic determinants of health. Cutaneous disease, both infectious and i...
| Publicado en: | Wound Practice & Research Vol. 30; no. 1; pp. 34 - 40 |
|---|---|
| Autores principales: | , , , |
| Formato: | pictorial review tables/charts Journal Article |
| Publicado: |
Cambridge Publishing
Mar2022
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=156117169&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 156117169 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 18376304 639G jtl: Wound Practice & Research issn: 18376304 maglogo: N pubinfo: dt: Mar2022 vid: 30 iid: 1 pid: 66266 pub: Cambridge Publishing artinfo: ui: 156117169 156117169 156117169 10.33235/wpr.30.1.34-39 156117169 ppf: 34 ppct: 6 formats: fmt: @attributes: type: P tig: atl: Cutaneous infection and atopic dermatitis: the importance of early intervention in Indigenous children in Australia. aug: au: Russell, Rhiannon Slape, Dana McCrossin, Ian Frew, John W. affil: The Wollongong Hospital, Wollongong, NSW, Australia sug: subj: Dermatitis, Atopic Complications First Nations of Australia In Infancy and Childhood Dermatitis, Atopic Therapy Infection Risk Factors Patient Compliance Evaluation Patient Safety Health Services Accessibility Chronic Disease Risk Factors Early Childhood Intervention Social Determinants of Health Healthcare Disparities Child Dermatitis, Atopic Epidemiology Risk Assessment Cost Benefit Analysis Streptococcal Infections Complications Child: 6-12 years ab: There are dramatic disparities in the life expectancy, health and healthcare access between Indigenous and non-Indigenous Australians. The burden of chronic disease is significantly elevated and contributed to by multiple socioeconomic determinants of health. Cutaneous disease, both infectious and inflammatory, have major contributions to the risk of developing chronic disease in later life and contributing to barriers to education, employment and healthcare. Atopic dermatitis (AD) is a common, burdensome inflammatory skin disease worldwide; however, a paucity of literature exists reviewing the prevalence in Indigenous Australians. Typical therapies of AD are time-consuming and burdensome and can be an additional barrier to treatment compliance. However, multiple novel targeted therapeutics now exist for the effective and safe management of AD which are demonstrated to reduce the risk of cutaneous infections. Effective early and prioritised access to such therapies in the setting of moderate to severe AD may represent a potential intervention, with downstream benefits in the development of chronic disease. Nevertheless, there are multiple outstanding questions regarding the safety of such therapies in the setting of endemic infections such as scabies and strongyloidiasis which require attention, as well as the practicalities for such therapies to be administered in rural and remote communities. Overall, the appreciation of the role of cutaneous inflammatory and infectious disease as a contributor to health disparities in Indigenous populations is sorely needed. Discussion regarding the risk-benefit and cost-efficacy of targeted therapeutics in moderate to severe AD and consideration of prioritised access to Indigenous patients in need should be undertaken as part of a wider health prevention strategy with community input. pubtype: Academic Journal doctype: pictorial review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|